Table 3.

Relative bioavailability of flunixin meglumine compounded with iron dextran (F+ID) and meloxicam compounded with iron dextran (M+ID) versus flunixin meglumine (F) and meloxicam (M) alone in piglets.

Parameter	Unit	Ratio of least-squares means (F+ID/F)	90% CI
			LL	UL
Flunixin meglumine
AUC0–tlast	h*μg/mL	0.70*	0.56	0.89
AUC0–∞	h*μg/mL	0.70*	0.56	0.89
Parameter	Unit	Ratio of least-squares means (M+ID/M)	90% CI
			LL	UL
Meloxicam
AUC0–tlast	h*μg/mL	0.53*	0.42	0.68
AUC0–∞	h*μg/mL	0.53*	0.42	0.68

AUC_0–tlast — area under the concentration time curve from time zero to last measured concentration. AUC_0–∞ — AUC from time zero to infinity. The differences in the ratio of least squares means were analyzed by 2-sample t-test.

^*Indicates significant difference (P < 0.05) based on the 90% confidence intervals (CI) not including 1.